These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38514158)

  • 1. Flecainide causing elevated capture thresholds on pacemaker implantation.
    Leow KC; Lim WY; Lee A; Rahman M; Tan R
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture.
    Suffredini JM; Rutland J; Akpunonu P; Baum R; Catanzaro J; Elayi CS
    Am J Case Rep; 2019 Aug; 20():1279-1283. PubMed ID: 31467262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide toxicity with high pacemaker capture thresholds and associated takotsubo syndrome.
    Manley-Casco D; Crass S; Alqusairi R; Girard S
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34362750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide-induced AV dyssynchrony and atrial latency progression in a patient with a dual-chamber pacemaker.
    Alston M; Chang D; Mitra R
    J Cardiovasc Electrophysiol; 2021 Jul; 32(7):2005-2010. PubMed ID: 34053127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.
    Apps A; Miller CP; Fellows S; Jones M
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26286909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased capture threshold in permanent His-bundle pacing associated with flecainide.
    Jiang M; Wasserlauf J; Knight BP; Verma N
    Pacing Clin Electrophysiol; 2020 Apr; 43(4):360-363. PubMed ID: 32010978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate.
    Fornieles-Pérez H; Montoya-García M; Levine PA; Sanz O
    Pacing Clin Electrophysiol; 2002 May; 25(5):871-2. PubMed ID: 12049386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent pacemaker syndrome: revision of VVI pacemaker to a new cardiac pacing mode for tachy-brady syndrome.
    McCormick DJ; Shuck JW; Ansinelli RA
    Pacing Clin Electrophysiol; 1987 Mar; 10(2):372-7. PubMed ID: 2437541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute loss of capture due to flecainide acetate.
    Antonelli D; Freedberg NA; Rosenfeld T
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1170. PubMed ID: 11475838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference by antiarrhythmic agents with function of electrical cardiac devices.
    Tworek DA; Nazari J; Ezri M; Bauman JL
    Clin Pharm; 1992 Jan; 11(1):48-56. PubMed ID: 1730178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds.
    Hellestrand KJ; Burnett PJ; Milne JR; Bexton RS; Nathan AW; Camm AJ
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):892-9. PubMed ID: 6195608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A somnolent woman in her fifties with acute circulatory failure.
    Viland J; Langørgen J; Wendelbo Ø
    Tidsskr Nor Laegeforen; 2019 May; 139(9):. PubMed ID: 31140247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide-induced myalgias and weakness: a rare adverse reaction.
    Kumar D; Rehman ME; Mersfelder T; Patel P
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a single oral dose of pilsicainide on pacing thresholds in pacemaker patients with and without paroxysmal atrial fibrillation.
    Numata T; Abe H; Nagatomo T; Kohshi K; Nakashima Y
    Jpn Circ J; 2000 Oct; 64(10):750-4. PubMed ID: 11059614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Preventive" pacing in patients with tachy-brady syndrome (TBS): Confirming a common practice.
    Amir T; Ilan M; Fishman E; Michowitz Y; Khalameizer V; Katz A; Glikson M; Medina A; Rav Acha M
    Int J Clin Pract; 2020 Oct; 74(10):e13583. PubMed ID: 32533880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.